FDA Drug Application (103786) for RETAVASE by EKR THERAP

Back to FDA Applications sponsored by EKR THERAP

Application Number103786
Product Number001
FormVIAL
Dosage18.8MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRETAVASE
Active IngredientRETEPLASE



Back to FDA Applications sponsored by EKR THERAP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.